home / stock / act / act news


ACT News and Press, AdvisorShares Vice ETF From 09/20/19

Stock Information

Company Name: AdvisorShares Vice ETF
Stock Symbol: ACT
Market: NASDAQ
Website: enactmi.com

Menu

ACT ACT Quote ACT Short ACT News ACT Articles ACT Message Board
Get ACT Alerts

News, Short Squeeze, Breakout and More Instantly...

ACT - Cannabis Investing: Maximize Your Chance For Success

Introduction Cannabis is a once-in-a-generation investment opportunity. The chance to invest in an industry in its infancy with so much growth in its future is rare and shouldn't be missed. There are other high-growth industries, but as described below, cannabis offers a constellation of dri...

ACT - Cannabis Trade Show Testimony With Greg Marco

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Greg Marco, President of Leading Edge Expositions, which produces the CWCBExpo ....

ACT - The Changing Cannabis Narrative With Debra Borchardt

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Debra Borchardt . Debra is the CEO, Co-founder, and Editor-in-Chief of t...

ACT - Shifting Focus From Cannabis To Other Cannabinoids With Ronan Levy, Trait Biosciences

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Ronan Levy, Chief Strategy Officer at Trait Biosciences, a cannabis biotech firm....

ACT - Revenue And Profit Aren't Mutually Exclusive With Joe Lusardi, Curaleaf CEO

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am excited to be joined by Joe Lusardi, President & CEO of Curaleaf (CURLF), a vertically integrated m...

ACT - FDA reopens public comment period on cannabis product scheduling

The FDA has reopened its 30-day comment period related to international drug scheduling on cannabis products. A delay from the World Health Organization disrupted the original schedule. More news on: Cronos Group Inc., Tilray, Inc., Aurora Cannabis Inc., Healthcare stocks news, Consumer ...

ACT - Curing And Drying Cannabis With David Sandelman

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by David Sandelman, Chief Engineer at Cannatrol, a precision drying/curing system fo...

ACT - Cannabis' Tissue Culture Technology With David Brough

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by David Brough, CEO of Klonetics Plant Science. He's also President at Precisi...

ACT - Pot stocks under pressure after Tilray reports big drop in average sale price

The broad market's sell-off notwithstanding, cannabis stocks are under pressure after Tilray reported Q2 results after the close yesterday. Revenues were up 371% to $45.9M, albeit from a low base. Investors appear to be reacting to its disclosure that the average price per gram sold droppe...

ACT - The Importance Of Developing IPs, With Dr. Kyle Kingsley, Vireo Health

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by Dr. Kyle Kingsley, the founder and CEO of Vireo Health (VREOF), a publicly t...

Previous 10 Next 10